BioSpace News Archive

Yancopoulos, Regeneron’s founder and chief scientific officer, and Schleifer, chief executive officer, argue in the article that while drug affordability is important, the single-minded argument detracts from “the overwhelming health care crisis facing our society” and creates a negative image of an industry that provides substantial benefit to society.

Strength of Business Transformation Efforts Continue to Drive Revenue, Profit Growth

Exicure, Inc. reported financial results for the second quarter ended June 30, 2018, and provided an update on corporate progress.

GI Partners announced today that it has completed the previously announced acquisition and merger of California Cryobank (CCB), the world’s premier donor sperm and egg bank, and Cord Blood Registry (CBR), the world’s largest stem cell collection and storage company.

Fluidic Analytics Ltd, has announced the issuance of US Patent 9,952,22 B2, entitled ‘Fluidic Separation and Detection’, from the United States Patent and Trademark Office.

CryoLife, Inc. announced today its financial results for the second quarter ended June 30, 2018.

India Globalization Capital, Inc. announces that during its Annual Meeting of Shareholders scheduled for, and convened on August 6, 2018, voting on all matters as disclosed on the Definitive Proxy on Form 14A filed with the SEC on July 6, 2018 were passed.

Dosed the First Patient in DUET-2, Phase 1 Clinical Trial of Lead Tumor Microenvironment (TME) Activator XmAb®20717 in Advanced Solid Tumors

Revenue up 142 Percent, Global install base up 25 Percent

TherapeuticsMD, Inc. announced the closing of its previously announced $65 million underwritten public offering of common stock, at a price to the public of $5.10 per share, and concurrent $20 million registered direct offering of common stock to a strategic investor at a price of $5.10 per share.